RAD52 and cancer: Motivated by their previous evidence in budding yeast Rad52 [121], they confirmed that curcumin inhibited RAD52 expression in human cancer cells too, using the MCF-7 cell line treated with the irinotecan (CPT-11) damaging agent and then with different curcumin conditions.